These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Beta-amyloid sequelae in the eye: a critical review on its diagnostic significance and clinical relevance in Alzheimer's disease. Shah TM; Gupta SM; Chatterjee P; Campbell M; Martins RN Mol Psychiatry; 2017 Mar; 22(3):353-363. PubMed ID: 28093567 [TBL] [Abstract][Full Text] [Related]
7. Potential therapeutic implications of gelsolin in Alzheimer's disease. Ji L; Zhao X; Hua Z J Alzheimers Dis; 2015; 44(1):13-25. PubMed ID: 25208622 [TBL] [Abstract][Full Text] [Related]
8. Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis. Viola KL; Klein WL Acta Neuropathol; 2015 Feb; 129(2):183-206. PubMed ID: 25604547 [TBL] [Abstract][Full Text] [Related]
9. Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer's disease. Thal DR; Walter J; Saido TC; Fändrich M Acta Neuropathol; 2015 Feb; 129(2):167-82. PubMed ID: 25534025 [TBL] [Abstract][Full Text] [Related]
10. Key Peptides and Proteins in Alzheimer's Disease. Penke B; Bogár F; Paragi G; Gera J; Fülöp L Curr Protein Pept Sci; 2019; 20(6):577-599. PubMed ID: 30605056 [TBL] [Abstract][Full Text] [Related]
11. Revisiting the Amyloid Cascade Hypothesis: From Anti-Aβ Therapeutics to Auspicious New Ways for Alzheimer's Disease. Uddin MS; Kabir MT; Rahman MS; Behl T; Jeandet P; Ashraf GM; Najda A; Bin-Jumah MN; El-Seedi HR; Abdel-Daim MM Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824102 [TBL] [Abstract][Full Text] [Related]
12. Brain amyloid-beta fragment signatures in pathological ageing and Alzheimer's disease by hybrid immunoprecipitation mass spectrometry. Portelius E; Lashley T; Westerlund A; Persson R; Fox NC; Blennow K; Revesz T; Zetterberg H Neurodegener Dis; 2015; 15(1):50-7. PubMed ID: 25591542 [TBL] [Abstract][Full Text] [Related]
13. Mirror Image of the Amyloid-β Species in Cerebrospinal Fluid and Cerebral Amyloid in Alzheimer's Disease. Catania M; Di Fede G; Tonoli E; Benussi L; Pasquali C; Giaccone G; Maderna E; Ghidoni R; Tagliavini F J Alzheimers Dis; 2015; 47(4):877-81. PubMed ID: 26401767 [TBL] [Abstract][Full Text] [Related]
14. Amyloid-β: the seeds of darkness. Fodero-Tavoletti MT; Villemagne VL; Rowe CC; Masters CL; Barnham KJ; Cappai R Int J Biochem Cell Biol; 2011 Sep; 43(9):1247-51. PubMed ID: 21601003 [TBL] [Abstract][Full Text] [Related]
15. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters. Matsuzaki K Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558 [TBL] [Abstract][Full Text] [Related]
16. Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease. Li S; Jin M; Liu L; Dang Y; Ostaszewski BL; Selkoe DJ Acta Neuropathol Commun; 2018 Nov; 6(1):121. PubMed ID: 30409172 [TBL] [Abstract][Full Text] [Related]